
|Articles|June 5, 2012
ASCO: Cymbalta Tames Post-Chemo Pain
Advertisement
The antidepressant duloxetine (Cymbalta) appears to cut down on the numbness and tingling associated with taxane or platinum-based chemotherapy, according to clinical trial results.
Pain from chemotherapy-induced peripheral neuropathy and its interference with daily life fell significantly with the drug, Ellen Lavoie Smith, PhD, of the University of Michigan School of Nursing in Ann Arbor, and colleagues found.
A clinically significant 30% or greater reduction in pain scores occurred in 33% of duloxetine-treated patients compared with 17% of placebo-treated patients, they reported here at the American Society of Clinical Oncology meeting.
Read the full story:
Source: MedPage Today
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Vutrisiran Effects Consistent With, Without Tafamidis in ATTR-CM
2
FDA Approves Camizestrant for ER+, HER2– mBC With ESR1 Mutations
3
Multiagonists Outpace Older GLP-1 Drugs for Weight Loss
4
Cardiac Risks of COVID-19 Vaccine vs Infection: Eman Toraih, MD, PhD
5




